NARCOMS 登记处:多发性硬化症登记处 (NARCOMS)
NARCOMS 全球多发性硬化症登记处:一项促进多发性硬化症研究的长期研究
该项目基于这样一种想法,即我们可以通过在数年内跟踪一大群人的疾病和治疗模式来了解 MS 的复杂性。 收集的信息仅用于研究。 结果仅以摘要形式呈现。 注册参与者提交的所有详细信息均严格保密。
要参加 NARCOMS,请通过 www.narcoms.org 在线完成基线注册调查 (或直接使用以下链接:https://redcap.link/py2rnyyn) 或者您可以通过发送电子邮件至 MSregistry@narcoms.org 请求将邮寄调查发送给您。 您将被要求每年两次在线或通过邮件更新您的信息。 每次更新调查通常只需不到 20 分钟即可完成。
参与无需任何费用。 对于您的参与,您可以免费订阅 NARCOMS 季刊 NARCOMS Now。 NARCOMS Now 提供有关最新 MS 研究和疾病管理的可靠信息来源。 您可以随时停止参与注册表。
您可能还会收到有关临床试验的其他调查或信息。 您没有义务参与,这些额外的研究将始终直接来自 NARCOMS。 您的联系信息不会被分享或出售给其他方。
研究概览
地位
条件
详细说明
位于德克萨斯大学西南医学中心的数据协调中心负责维护 NARCOMS,这是世界上最大的自愿、患者驱动的 MS 注册中心。 该登记处涉及美国和加拿大至少三个其他地点(克利夫兰诊所基金会、阿拉巴马大学伯明翰分校和加拿大曼尼托巴大学)的人员。 在过去的 20 年里,美国、加拿大和其他 50 多个国家/地区的 41,000 多名 MS 患者,包括 4,000 多名退伍军人,通过邮寄或在线提交他们的健康相关数据参与了登记。 注册数据已在 100 多篇同行评审的期刊文章、科学海报和演示文稿中出现。 这些报告提供了指导新研究的信息。 他们还提供了支持批准新药治疗 MS 的证据。
北美多发性硬化症研究委员会 (NARCOMS) 得到了多发性硬化症中心联合会 (CMSC) 的部分支持,CMSC 是一个为多发性硬化症 (MS) 医疗保健提供者和研究人员服务的非营利性专业组织,涉及 198 个参与中心MS 治疗和研究社区。
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:NARCOMS Team
- 电话号码:1-214-648-4583
- 邮箱:MSregistry@narcoms.org
学习地点
-
-
Texas
-
Dallas、Texas、美国、75390-8806
- 招聘中
- UT Southwestern Medical Center
-
接触:
- NARCOMS Team
- 电话号码:214-648-4583
- 邮箱:MSregistry@narcoms.org
-
首席研究员:
- Amber Salter, Ph.D.
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
取样方法
研究人群
描述
纳入标准:
- 任何被诊断患有多发性硬化症或临床孤立综合征的人
- 必须年满 18 岁
排除标准:
- 没有任何
学习计划
研究是如何设计的?
设计细节
- 观测模型:其他
- 时间观点:预期
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
随随访时间的疾病进展
大体时间:长达15年
|
使用患者确定的疾病步骤测量疾病进展
|
长达15年
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
改变 MS 疾病状态的影响因素
大体时间:长达15年
|
因素包括但不限于人口统计学、生活方式和临床特征
|
长达15年
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
多发性硬化症的药物使用
大体时间:长达15年
|
从参与者那里收集疾病改善疗法的使用
|
长达15年
|
合作者和调查者
调查人员
- 研究主任:Robert J. Fox, M.D.、Mellen Center for MS / Cleveland Clinic
- 首席研究员:Amber Salter, Ph.D.、University of Texas Southwestern Medical Center
- 研究主任:Gary R Cutter, Ph.D.、University of Alabama at Birmingham
- 研究主任:Ruth Ann Marrie, M.D., Ph.D.、Dalhousie University
出版物和有用的链接
一般刊物
- Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.
- Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009 Jan 13;72(2):117-24. doi: 10.1212/01.wnl.0000333252.78173.5f. Epub 2008 Oct 29.
- Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand. 2012 Mar;125(3):180-6. doi: 10.1111/j.1600-0404.2011.01526.x. Epub 2011 May 26.
- Buchanan RJ, Radin D, Chakravorty BJ, Tyry T. Informal care giving to more disabled people with multiple sclerosis. Disabil Rehabil. 2009;31(15):1244-56. doi: 10.1080/09638280802532779.
- Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007 Jan;127(1-2):35-41. doi: 10.1016/j.pain.2006.07.015. Epub 2006 Sep 1.
- Salter A, Thomas N, Tyry T, Cutter G, Marrie RA. Employment and absenteeism in working-age persons with multiple sclerosis. J Med Econ. 2017 May;20(5):493-502. doi: 10.1080/13696998.2016.1277229. Epub 2017 Jan 25.
- Mahajan ST, Patel PB, Marrie RA. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry. J Urol. 2010 Apr;183(4):1432-7. doi: 10.1016/j.juro.2009.12.029. Epub 2010 Feb 20.
- Buchanan RJ, Chakravorty BJ, Tyry T, Hatcher W, Vollmer T. Age-related comparisons of people with multiple sclerosis: demographic, disease, and treatment characteristics. NeuroRehabilitation. 2009;25(4):271-8. doi: 10.3233/NRE-2009-0525.
- Marrie RA, Cutter G, Tyry T, Vollmer T. A cross-sectional study of bone health in multiple sclerosis. Neurology. 2009 Oct 27;73(17):1394-8. doi: 10.1212/WNL.0b013e3181beece8.
- Hadjimichael O, Vollmer T, Oleen-Burkey M; North American Research Committee on Multiple Sclerosis. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.
- Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T. Smoking status over two years in patients with multiple sclerosis. Neuroepidemiology. 2009;32(1):72-9. doi: 10.1159/000170910. Epub 2008 Nov 12.
- Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler. 2009 Jan;15(1):105-13. doi: 10.1177/1352458508096680. Epub 2008 Oct 9.
- Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008 Sep;14(8):1091-8. doi: 10.1177/1352458508092263.
- Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol. 2008 Sep;255(9):1354-60. doi: 10.1007/s00415-008-0910-y. Epub 2008 Jul 17.
- Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Disparities in the management of multiple sclerosis-related bladder symptoms. Neurology. 2007 Jun 5;68(23):1971-8. doi: 10.1212/01.wnl.0000264416.53077.8b.
- Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T. Validation of the NARCOMS registry: diagnosis. Mult Scler. 2007 Jul;13(6):770-5. doi: 10.1177/1352458506075031. Epub 2007 Mar 15.
- Kobelt G, Berg J, Atherly D, Hadjimichael O. Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology. 2006 Jun 13;66(11):1696-702. doi: 10.1212/01.wnl.0000218309.01322.5c.
- Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D. Does multiple sclerosis-associated disability differ between races? Neurology. 2006 Apr 25;66(8):1235-40. doi: 10.1212/01.wnl.0000208505.81912.82.
- Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Changes in the ascertainment of multiple sclerosis. Neurology. 2005 Oct 11;65(7):1066-70. doi: 10.1212/01.wnl.0000178891.20579.64.
- Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Validation of the NARCOMS registry: fatigue assessment. Mult Scler. 2005 Oct;11(5):583-4. doi: 10.1191/1352458505ms1216oa.
- Marrie RA, Cutter G, Tyry T, Hadjimichael O, Vollmer T. Validation of the NARCOMS Registry: pain assessment. Mult Scler. 2005 Jun;11(3):338-42. doi: 10.1191/1352458505ms1167oa.
- Lo AC, Hadjimichael O, Vollmer TL. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler. 2005 Feb;11(1):33-40. doi: 10.1191/1352458505ms1136oa.
- Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004 Oct;10(5):589-95. doi: 10.1191/1352458504ms1085oa.
- Marrie RA, Hadjimichael O, Vollmer T. Predictors of alternative medicine use by multiple sclerosis patients. Mult Scler. 2003 Oct;9(5):461-6. doi: 10.1191/1352458503ms953oa.
- Buchanan R, Radin D, Chakravorty BJ, Tyry T. Perceptions of informal care givers: health and support services provided to people with multiple sclerosis. Disabil Rehabil. 2010;32(6):500-10. doi: 10.3109/09638280903171485.
- Finlayson M, Cho C. A descriptive profile of caregivers of older adults with MS and the assistance they provide. Disabil Rehabil. 2008;30(24):1848-57. doi: 10.1080/09638280701707324.
- Fraser C, Hadjimichael O, Vollmer T. Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis. J Neurosci Nurs. 2003 Jun;35(3):163-70. doi: 10.1097/01376517-200306000-00006.
- Fraser C, Morgante L, Hadjimichael O, Vollmer T. A prospective study of adherence to glatiramer acetate in individuals with multiple sclerosis. J Neurosci Nurs. 2004 Jun;36(3):120-9. doi: 10.1097/01376517-200406000-00002.
- Buchanan RJ, Minden SL, Chakravorty BJ, Hatcher W, Tyry T, Vollmer T. A pilot study of young adults with multiple sclerosis: demographic, disease, treatment, and psychosocial characteristics. Disabil Health J. 2010 Oct;3(4):262-70. doi: 10.1016/j.dhjo.2009.09.003. Epub 2009 Nov 26.
- Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2011 Aug;124(2):135-41. doi: 10.1111/j.1600-0404.2010.01436.x. Epub 2010 Sep 29.
- Salter AR, Cutter GR, Tyry T, Marrie RA, Vollmer T. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin. 2010 Feb;26(2):493-500. doi: 10.1185/03007990903500649.
- Buchanan RJ, Zuniga MA, Carrillo-Zuniga G, Chakravorty BJ, Tyry T, Moreau RL, Huang C, Vollmer T. Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis. Ethn Dis. 2010 Autumn;20(4):451-7.
- Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases. Neuroepidemiology. 2011;36(2):85-90. doi: 10.1159/000323948. Epub 2011 Feb 1.
- Cutter GR, Zimmerman J, Salter AR, Knappertz V, Suarez G, Waterbor J, Howard VJ, Marrie RA. Causes of death among persons with multiple sclerosis. Mult Scler Relat Disord. 2015 Sep;4(5):484-490. doi: 10.1016/j.msard.2015.07.008. Epub 2015 Jul 18.
- Bethoux F, Marrie RA. A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis. Patient. 2016 Dec;9(6):537-546. doi: 10.1007/s40271-016-0173-0.
- Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR. Health insurance affects the use of disease-modifying therapy in multiple sclerosis. Neurology. 2016 Jul 26;87(4):365-74. doi: 10.1212/WNL.0000000000002887. Epub 2016 Jun 29.
- Salter A, Tyry T, Wang G, Fox RJ, Cutter G, Marrie RA. Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS. Neurol Clin Pract. 2016 Oct;6(5):397-408. doi: 10.1212/CPJ.0000000000000269.
- Reider N, Salter AR, Cutter GR, Tyry T, Marrie RA. Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis. Res Nurs Health. 2017 Apr;40(2):143-152. doi: 10.1002/nur.21783. Epub 2017 Feb 6.
- Marrie RA, Salter A, Tyry T, Cutter GR, Cofield S, Fox RJ. High hypothetical interest in physician-assisted death in multiple sclerosis. Neurology. 2017 Apr 18;88(16):1528-1534. doi: 10.1212/WNL.0000000000003831. Epub 2017 Mar 15.
- Marrie RA, Cutter GR, Tyry T, Cofield SS, Fox R, Salter A. Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis. Mult Scler Relat Disord. 2017 Apr;13:87-92. doi: 10.1016/j.msard.2017.02.013. Epub 2017 Feb 20.
- Salter A, Thomas NP, Tyry T, Cutter GR, Marrie RA. A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry. Mult Scler. 2018 Jun;24(7):951-962. doi: 10.1177/1352458517711274. Epub 2017 May 19.
- Marrie RA, Sharma M, Cutter GR, Fox RJ, Salter A. Perspectives of People With Multiple Sclerosis Regarding Data Linkage and Sharing. Neurology. 2025 May 13;104(9):e213587. doi: 10.1212/WNL.0000000000213587. Epub 2025 Apr 8.
- Salter A, Lancia S, Sharma M, Cutter GR, Fox RJ, Marrie RA. Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis. Neurol Clin Pract. 2025 Aug;15(4):e200493. doi: 10.1212/CPJ.0000000000200493. Epub 2025 Jun 4.
- Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA. Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis. Neurology. 2025 Jan 28;104(2):e210149. doi: 10.1212/WNL.0000000000210149. Epub 2024 Dec 23.
- O'Mahony J, Salter A, Ciftci-Kavaklioglu B, Fox RJ, Cutter GR, Marrie RA. Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis. Neurology. 2022 Oct 3;99(14):e1538-e1548. doi: 10.1212/WNL.0000000000200931.
- Marrie RA, Cutter GR, Fox RJ, Vollmer T, Tyry T, Salter A. NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights. Int J MS Care. 2021 Nov-Dec;23(6):276-284. doi: 10.7224/1537-2073.2020-133. Epub 2021 Dec 29.
研究记录日期
研究主要日期
学习开始
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (估计的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.